RenalSense has started commercial sales of its Clarity RMS™ system in Europe with its distribution partner Fresenius Medical Care (Bad Homburg). The Clarity RMS received

Genetika + is a Jerusalem based biotech start-up developing cutting edge technology to determine which anti-depressant is best suited to each patient. When Treating a

Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax’s M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical Trials Data published on Clinicaltrials.gov

BrainsWay Ltd. achieved final positive results from its pivotal multicenter trial on the safety and efficacy of the Company’s H4 Deep transcranial magnetic stimulation system

Zygosid-50, a drug under development in Israel, could be the first to treat type 2 diabetes by restoring the body’s insulin sensitivity, without side effects.

Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the U.S. launch of its

Following achievement of an important milestone for Stem-Cell based cancer treatments resistance diagnostics, Jerusalem based NewStem received a further $ 1 million follow-on investment from

Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with the participation of existing investors Dr. Shmuel Cabilly

Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically lowers insulin resistance, the major